Health Condition 1: N768- Other specified inflammation of vagina and vulva
Conditions
Interventions
Intervention1: Probiotics in addition to conventional antifungal: Conventional antifungal treatment along with probiotics will be given to those newly diagnosed vulvovaginal candidiasis and followed
Sponsors
Lady Hardinge Medical College
Eligibility
Inclusion criteria
Inclusion criteria: All females aged 18-50 years diagnosed with vulvovaginal candidiasis. Diagnosis of VVC will be confirmed by the presence of clinical symptoms and signs, and a positive microscopic examination or positive vaginal culture or both.
Exclusion criteria
Exclusion criteria: Pregnant and lactating females. Recurrent vulvovaginal candidiasis (4 or more episodes of symptomatic vulvovaginal candidiasis within 1 year) Vaginal discharge other than those of candidiasis or mixed infection Taking any kind of treatment for vulvovaginal candidiasis/ probiotics within last one month. Other pathologies (immunodeficiency, diabetes) Patient not willing for sexual abstinence/barrier protection during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical cure rate (the ratio between the number of women without vaginal discharge or itching and all women present in the treatment group)Timepoint: week 1, week 2, week 4, week 8 | — |
Secondary
| Measure | Time frame |
|---|---|
| Mycological cure rate (the ratio between the number of women with negative culture and all women present in the treatment group) Relapse rate (ratio between the number of women experiencing at least one symptom during the 2-month follow-up period, confirmed by culture, and all women present in the treatment group) Time to first relapse Proportion of patient having side effects Patient assesment score in both the treatment groupTimepoint: week 1, week 2, week 4, week 8 | — |
Countries
India
Contacts
Public ContactVibhu Mendiratta
Lady Hardinge Medical college
Outcome results
None listed